share_log

Why Reata Pharmaceuticals Shares Are Trading Higher By 140%; Here Are 20 Stocks Moving Premarket

Why Reata Pharmaceuticals Shares Are Trading Higher By 140%; Here Are 20 Stocks Moving Premarket

為什麼雷塔醫藥股票交易較高 140％; 這裡有 20 股移動前市場
Benzinga ·  2023/03/01 07:57

Gainers

漲幅

  • Reata Pharmaceuticals Inc (NASDAQ:RETA) rose 140.8% to $75.06 in pre-market trading after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia.
  • OncoSec Medical Incorporated (NASDAQ:ONCS) rose 75.9% to $1.90 in pre-market trading after the company requests withdrawal of registration statement, The company said it has opted not to pursue offering thereby at this time.
  • Lionheart III Corp (NASDAQ:LION) shares rose 56.2% to $22.80 in pre-market trading after jumping around 98% on Tuesday.
  • China Pharma Holdings Inc (NASDAQ:CPHI) rose 20.8% to $0.081 in pre-market trading. China Pharma recently announced a 1-for-10 reverse stock split.
  • Helbiz Inc (NASDAQ:HLBZ) rose 19.1% to $0.17 in pre-market trading after gaining over 21% on Tuesday.
  • Sarepta Therapeutics Inc (NASDAQ:SRPT) rose 17% to $142.90 in pre-market trading after the company reported better-than-expected Q4 results.
  • Landos Biopharma Inc (NASDAQ:LABP) shares rose 14.9% to $0.43 in pre-market trading. Landos Biopharma announced transfer of LANCL portfolio, including Omilancor, LABP-104 and LABP-111 to Landos' founder.
  • China SXT Pharmaceuticals Inc (NASDAQ:SXTC) rose 14.7% to $0.45 in pre-market trading after gaining over 3% on Tuesday.
  • Cerevel Therapeutics Holdings Inc (NASDAQ:CERE) rose 9.7% to $29.30 in pre-market trading. Cerevel Therapeutics recently posted a narrower-than-expected quarterly loss.
  • Bilibili Inc - ADR (NASDAQ:BILI) shares rose 8.8% to $21.00 in pre-market trading after dropping over 3% on Tuesday.
  • 雷塔製藥公司 該公司報告了美國食品和藥物管理局批准了弗里德瑞希共濟失調患者的 SKYCLARYS 批准後，在上市前交易中上漲了 140.8%，至 75.06 美元。
  • 安科醫療有限公司 （NASDAQ：ONCS）在公司要求撤回註冊聲明後，上市前交易上漲 75.9% 至 1.90 美元。該公司表示，目前已選擇不從而進行發售。
  • 獅心三 （納斯達克：獅子）股票在市場前交易中上漲 56.2%，至 22.80 美元。
  • 中國醫藥控股有限公司 在市場前交易中，納斯達克：國際貨幣投資指數上漲 20.8%，至 0.081 美元。中國製藥公司最近宣布了一對十的反向股票拆股。
  • 乐乐商 週二收益超過 21% 後，盤前交易中上漲 19.1% 至 0.17 美元。
  • 薩雷普塔治療公司 公司報告的第四季業績好於預期後，上漲 17% 至 142.90 美元。
  • 兰多斯生物制藥股份有限公司 在盤前交易中，股票上漲 14.9%，至 0.43 美元。蘭多斯生物製藥宣布將蘭蔻投資組合（包括奧米蘭科、LABP-104 和 LABP-111）轉移給蘭多斯的創始人。
  • 中國 SXT 製藥公司 (納斯達克:SXTC) 在星期二收益超過 3% 後，上漲 14.7% 至 0.45 美元。
  • 雪佛治療控股有限公司 納斯達克：塞爾）在市場前交易中上漲 9.7%，至 29.30 美元。Cerevel 治療最近發布了比預期更窄的季度虧損。
  • 比利比利股份有限公司-ADR （納斯達克：比利）股票在市場前交易中上漲 8.8%，至 21.00 美元。

Losers

失敗者

  • OKYO Pharma (NASDAQ:OKYO) fell 24.2% to $1.69 in pre-market. US Customs cleared OKYO Pharma's GMP packaged OK-101 drug for Phase 2 clinical trial for treating dry eye disease.
  • Novavax Inc (NASDAQ:NVAX) fell 24% to $7.04 in pre-market trading after the company reported worse-than-expected Q4 results and said substantial doubt exists regarding its ability to continue as a going concern.
  • Marqeta Inc (NASDAQ:MQ) fell 19.1% to $4.69 in pre-market trading after the company reported fourth-quarter results and issued guidance for slowing growth.
  • Beamr Imaging Ltd. (NASDAQ:BMR) shares fell 18.6% to $2.97 in pre-market trading. Beamr Imaging priced its initial public offering of 1,950,000 at a public offering price of $4.00 per share.
  • Obseva SA (NASDAQ:OBSV) shares dropped 15.2% to $0.12 in pre-market trading after jumping 43% on Tuesday. ObsEva recently announced strategic reorganization to consolidate operations in Switzerland.
  • Brightspire Capital Inc (NYSE:BRSP) fell 14.4% to $6.32 in pre-market trading after the company announced an offering of 30,358,213 shares by DigitalBridge Group, Inc.
  • Performance Shipping Inc (NASDAQ:PSHG) fell 13% to $2.34 in pre-market trading. Performance Shipping announced termination of at-the-market offering.
  • Grove Collaborative Holdings Inc (NYSE:GROV) fell 12.7% to $0.38 in pre-market trading.
  • Catalyst Biosciences Inc (NASDAQ:CBIO) fell 11.4% to $0.26 in pre-market trading. Catalyst Biosciences shares jumped around 24% on Tuesday after GC Biopharma signed an Asset Purchase Agreement with the company.
  • AMC Entertainment Holdings Inc (NYSE:AMC) shares fell 8.5% to $6.53 in pre-market trading after the company posted Q4 results. The company ended the quarter with available liquidity of $842.7 million and debt of $4.95 billion.
  • 大洋製藥 (納斯達克:OKYO) 在市場前下跌 24.2%，至 1.69 美元。美國海關通過 OKYO 製藥的 GMP 包裝 OK-101 藥物，用於治療乾眼疾的第二期臨床試驗。
  • 諾瓦克斯公司 NASDAQ：NVAX）在該公司報告第四季度業績差於預期之後，並表示對其繼續作為持續關注的能力存在重大懷疑之後，在市場前交易中下跌 24% 至 7.04 美元。
  • 马尔蓋塔 （納斯達克：MQ）在公司錄得第四季度業績並發布了增長放緩的指引後，在市場前交易中下跌 19.1% 至 4.69 美元。
  • 比姆影像有限公司 （納斯達克：BMR）股票在市場前交易中下跌 18.6%，至 2.97 美元。Beamr 成像以每股 4.00 美元的公開發售價格定價為 1,950,000 美元的首次公開發行。
  • 奧布塞瓦 SA 週二跳出 43% 後，股票在市前交易中下跌 15.2% 至 0.12 美元。Obseva 最近宣布了戰略重組，以鞏固瑞士的業務。
  • 百思柏資本公司 紐約證券交易所代碼：BRSP）在上市前交易中下跌 14.4% 至 6.32 美元後，該公司宣佈由數橋集團有限公司發行 30,358,213 股股份。
  • 性能航運公司 (納斯達克代碼:PSHG) 在盤前交易中下跌 13% 至 $2.34。性能航運宣布終止在市場上的產品。
  • 格羅夫協作控股公司 紐約證交所代碼：格羅夫）在市場前交易中下跌 12.7%，至 0.38 美元。
  • 催化劑生物科學公司 納斯達克：加拿大生物）在上市前交易中下跌 11.4%，至 0.26 美元。在 GC 生物製藥與公司簽署資產購買協議之後，催化劑生物科學股價在周二上漲了 24％ 左右。
  • AMC 娛樂控股 (紐約證交所代號:AMC) 在公佈第四季業績後，股票在上市前交易中下跌 8.5% 至 6.53 美元。該公司在本季度結束時，可用流動性為 842.7 億美元，債務為 49.5 億美元。

Now Read This: Top 5 Health Care Stocks That You May Want To Dump In Q1 2023

現在閱讀這個： 您可能想在 2023 年第一季轉儲的前 5 大醫療保健庫

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論